Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001145443-20-000092
Filing Date
2020-02-12
Accepted
2020-02-12 12:26:38
Documents
1
Group Members
MIML

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP enz3720821-sc13ga.htm SC 13G/A 77721
  Complete submission text file 0001145443-20-000092.txt   79232
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: SC 13G/A | Act: 34 | File No.: 005-32878 | Film No.: 20602599
SIC: 8071 Services-Medical Laboratories

Mailing Address 200 BLOOR ST EAST, NT-10 TORONTO A6 M4W1E5
Business Address 200 BLOOR ST EAST, NT-10 TORONTO A6 M4W1E5 416-926-3000
MANULIFE FINANCIAL CORP (Filed by) CIK: 0001086888 (see all company filings)

EIN.: 889897526 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6311 Life Insurance